African Journal of Primary Health Care & Family Medicine, AOSIS
1
Agudo C. T., Nattez S.G.V.
1
Alice Mark
1
Alyssa S. Parpia, Martial L. Ndeffo-Mbah, Natasha S. Wenzel, et al.
1
and J. Garcia-Rosales Delgado
1
Auerbach, R.
1
BAff
1
Brett D. Nelson, Maya Fehling, Margaret E. Tierna, Zina Maan Jarrah
1
British HIV Association
1
C. Hoffmann, A. Gualani Gualani
1
Camp, R. and C. Hoffmann
1
Charité
1
Chowell and Nishiura
1
Cotton, M., et al.
1
D. O’Mahony
1
Department of Health and Human Services
1
Department of Public Health, Ministry of Health, Gabarone, Botswana
1
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
1
Deutsche Gesellschaft für Tropenchirurgie
1
Environment International
1
Eric Maskin, Célestin Monga, Josselin Thuilliez and others
1
Fescina R, De Mucio B, Ortíz El, Jarkin D.
1
Fiona Charlson, Suhailah Ali, Jura Augustinavicius et al.
1
G. Rundgren and N. el-Hage Scialabba
1
Galarza, P. et al.
1
Ghanei, M.
1
Global Alliance for Vaccines and Immunisation (Gavi)
1
Global Healp
1
Harvard Humanitarian Initiative
1
HRSA
1
Human Rights Watch HRW
1
Imperial College COVID-19 Response Team
1
International Coll. Essential Surgery
1
International Diabetes Federation
1
International Journal of Mental Health Systems
1
International Rescue Committee
1
IPAS
1
IUCN (International Union for Conservation of Nature), KNCF (Keidanren Nature Conservation Fund)
1
John Hopkins Hospital antimicrobioal Stewardship Program
1
Jornal of Global Health Science
1
Journal of the International AIDS Society
1
Justin Cohen, Deepika Kandula, Bruno Moonen et al.
1
Kamhawi, S.
1
Katie Hayes, G. Blashki, J. Wiseman et al.
1
Khan, J.
1
M. Janier, V. Hegyi, N. Dupin et al
1
M. Mntonintshi
1
Malaria Journal
1
Mark, A.
1
Mary-Anne Hartley, Alyssa Young, Anh-Minh Tran et al.
1
McGloin, J.
1
Ministerio de Salud Argentina
1
Ministerio de salud pública y bienestar social, Organización Panamericana de la Salud, et al.
1
Ministry of Health & Ministry of Local Government, Gabarone, Botswana
1
Ministry of Health and Social Services (MOHSS)
1
Ministry of Health, Central Statistics Office & (DHS) Resource Development Inc.
1
Motaleb, Mohammad Abdul
1
Mukhtar A Adeiza, Abdullah A Abba, Juliana U Okpapi
1
NCBI (National Center for Biotechnology Information)
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Organisation Mondiale de la Santé OMS
1
Organisation mondiale de la Santé (OMS)
1
organisation mondiale de la Santé (OMS), Fédération internationale pharmaceutique (FIP)
1
Organización Mundial de la Salud (OMS), Federación Internacional Farmacéutica (FIP)
1
Organización Mundial de la Salud OMS
1
Ouédraogo M., Samadoulougou S., Rouamba T. et. al.
1
Pan American Health Organization PAHO
1
Panel on Antiretroviral Guidelines for Adults and Adolescents
1
PEPFAR
1
PLoS Neglected Tropical diseases
1
Plos One
1
Rafati, S.
1
Rutstein, S.E., J. Ananworanich, S. Fidler, et al.
1
S. Meshnick, M. Janko, S. Doctor, et al.
1
S. Ripoll and S. Carter
1
S.Mabunda
1
Sigmund Freud Privatuniversität
1
Social Science in Humanitarian Action
1
Susa Coffey,et al.
1
Tabitha Hrynick, T.
1
Teklemariam M., Assefa A., Kassa M., et al.
1
Torales, G.
1
UN Children's Fund
1
UNAIDS
1
UNICEF
1
US Department of Homeland Security, US Department of Health and Human Services
1
US Dept.Health
1
USAID
1
Valentuela, J.
1
Wamai, R.
1
World Health Organization (WHO), International Pharmaceutical Federation (FIP)
1
World Health Organization, et al.
1
Ziaggi, G.
1
Publication Years
2020-2024
58
2010-2019
9
2000-2009
5
Category
Studies & Reports
7
Malaria
6
Sexual Violence
4
Violence against Children
4
Women & Child Health
4
Drugs & Medical Equipment
3
HIV & STI
3
Disease Prevention & Control
3
Humanitarian Aid
2
COVID-19
2
Vector Control
2
Demograhic Health Surveys DHS
2
Policies & Guidelines HIV & TB
2
Guidelines
2
Immunization
2
Reproductive Health
2
Clinical Training
1
Sanitation
1
Diabetes
1
Hand Hygiene
1
Infection Control & Prevention (IPC)
1
Pediatrics
1
Policies
1
WASH
1
Surgery & Anaesthesia
1
Gynaecology & Obstetrics
1
Water
1
Pharmacy & Technologies
1
Toolboxes
Treatment Guidelines HIV
3
Pharmacy Practice
3
War & Conflict
2
Psychosocial Support (MHPSS)
2
Assessment & Studies
2
Surveillance
2
Mental Health
2
Clinical Guidelines
2
Global Impact: Socio-economic, health services, TB & HIV
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio...n WHA 70.16, which calls on Member States to develop or adapt national vector control strategies and operational plans to align with this strategy.more
Guiding framework for development cooperation, Working paper 2017.
This document was drawn up on the basis of expert publications and inputs from partners in the
GIZ regional programme Psychosocial Support for Syrian and Iraqi Refugees and Internally
Displaced People1 in order to serve as guidanc...e in the design, implementation and assessment of
psychosocial support measures for refugees in the context of the crises in Syria and Iraq. It is
aimed at actors from the MHPSS sector working with refugees in the Middle East and at ministries
and academic/scientific institutions in the context of the Syria and Iraq crises.more
Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...sistance Surveillance System (GLASS), the first global collaborative effort to foster AMR surveillance in bacteria causing acute infections. As of December 2018, 71 countries are enrolled in GLASS. The aim of this report is to document participation efforts and outcomes across these countries, and highlight differences and constraints identified to date. This report follows on from the first GLASS Report – Early implementation 2016-17, published in January 2018, and drawing on data from GLASS first data call in 2017.more
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...e decisions, measures and actions taken solely with the purpose of preventing and containing COVID-19, often without adequate consideration of how this affects the wider health system and pre-existing resource constraints.more
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...LASS report.
The fourth GLASS report summarizes the 2019 data reported to WHO in 2020. It includes data on AMC surveillance from 15 countries and AMR data on 3 106 602 laboratory-confirmed infections reported by 24 803 surveillance sites in 70 countries, compared to the 507 923 infections and 729 surveillance sites reporting to the first data call in 2017.
The report also describes developments over the past years of GLASS and other AMR surveillance programmes led by WHO, including resistance to anti-human immunodeficiency virus and anti-tuberculosis medicines, antimalarial drug efficacy.more
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i...nfection. In the context of growing global population immunity from COVID-19 vaccination and past SARS-CoV-2 infection, WHO recommends that identification, contact, quarantine and follow-up should be prioritized for individuals at high risk who have been in contact with a confirmed or probable case of SARS-CoV-2 infection, rather than targeting all contacts. This updated guidance also introduces shorter recommended quarantine periods, including the ability to further shorten quarantine through the use of testing. National and local health authorities should use risk-based approaches to contact tracing and quarantine that include reviewing and adjusting to their local circumstances and disease epidemiology, population immunity, their health system’s capacities, and risk tolerance.more
This article provides an overview of the current and projected climate change risks and impacts to mental health and provides recommendations for priority actions to address the mental health consequences of climate change.
Objetivo: Describir el perfil de sensibilidad y resistencia antimicrobiana de las bacterias “ESKAPE” aisladas en todas las unidades de internación del Hospital Del Norte durante la gestión 2019.
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...o protect populations from malaria (chemoprevention), while considering relevant measures of efficacy and the safety data needed to support WHO policy recommendations.more
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance... of antimicrobial consumption (AMC), invasive fungal infections, and a One Health surveillance model relevant to human health. To meet future challenges, it is in continuous evolution to enhance the quality and representativeness of data to inform the AMR burden accurately. As of the end of 2022, 127 countries, territories and areas participate in GLASS.
The fifth GLASS report, produced in collaboration with Member States, summarizes 2020 data on AMR rates in common bacteria from countries, territories, and areas. The report brings new features, including analyses of population testing coverage or AMR trends. For the first time, the report presents 2020 data on AMC at the national level. A new interactive dashboard allow users to explore AMR and AMC global data, country profiles and download the data.
This report marks the end of the early implementation phase of GLASS. In addition to presenting data collected through the latest data call, this report provides a summary of five years of national AMR surveillance data contributed to GLASS from its initiation, presents AMR findings in the context of progress of country participation in GLASS and in global AMR surveillance coverage and laboratory quality assurance systems at (sub)national level.
Patterns of antimicrobial consumption are presented by country with a particular focus on antibacterials. The report also presents the antimicrobial consumption according to the WHO AWaRe antibiotic classification, for penicillins and cephalosporines. From a One Health perspective, the report presents antimicrobial consumption data in the human sector expressed in tons to allow a comparison with antimicrobial consumption from other sectors (not included in this report).more
A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-ended list of some 20 parasitic, bact...erial, viral, protozoan and helminthic infections. Called “diseases of the poor,” because of their characteristic prevalence in poor populations regardless of a country's income status, they infect over one billion people in over 140 countries, with about 90% of the global burden in Africa. While NTDs do not contribute significantly to global deaths, they are debilitating and remain the most common infections among the poor worldwide, preventing them from escaping poverty by impacting livelihoods such as agriculture and livestock, and affecting cognitive, developmental and education outcomes.more
Traditional food markets play important economic, cultural, and social role and are sources of livelihood for millions of people in urban and rural areas. The manual Five keys for safer traditional food markets: risk mitigation in traditional food markets in the Asia-Pacific Region aims to support a...nd guide local authorities, market community, and consumers to transform these markets into safer and healthier places through practical risk mitigation measures and community engagement strategies. The manual provides guidance on the implementation of five keys to promote public health and safety, particularly, in the context of food safety, zoonoses diseases, and infectious respiratory diseases.more